A case report of fulminant cytokine release syndrome complicated by dermatomyositis after the combination therapy with immune checkpoint inhibitors

INTRODUCTION: Immune-related adverse events (ir-AEs) are increasingly becoming a concern, as immune checkpoint inhibitors (ICIs) are used more frequently. Herein, we present a case of fulminant cytokine release syndrome (CRS) complicated by dermatomyositis after the combination therapy with ICIs. PA...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohira, Junichiro, Kawamoto, Michi, Sugino, Yoshio, Kohara, Nobuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
3600
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220092/
https://www.ncbi.nlm.nih.gov/pubmed/32282733
http://dx.doi.org/10.1097/MD.0000000000019741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220092/
https://www.ncbi.nlm.nih.gov/pubmed/32282733
http://dx.doi.org/10.1097/MD.0000000000019741

Ejemplares similares